BeiGene shareholders approve redomestication from Cayman Islands to Switzerland at EGM

BeOne Medicines Ltd.

Special resolution to deregister in Cayman and continue to Switzerland passed with ~1.035B votes for, ~31K against.
Related amendment and restatement of articles (Proposed Swiss Articles) approved with similar overwhelming support.
Ernst & Young AG elected as Swiss statutory auditor until first AGM post-continuation; ~1.029B votes for.
Continuation remains subject to conditions and is expected to close later this year.
Quorum of ~74.6% of outstanding shares was present at the Extraordinary General Meeting on April 28, 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.